7/7/2020 6:50:02 AM
Annovis Bio Gets IRB Approval To Begin Phase 2 Clinical Study In Early PD And AD Patients At 15 Sites Across The US
5/27/2020 7:00:11 AM
Annovis Bio Files Patent Application For Method Of Preventing Or Treating Neurological Injuries